-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: BRIC
Small Biotech Companies and China: 5 Keys to Success
Big pharmaceutical countries aren’t the only ones investing in China. Emerging and mid-sized biotech companies are also exploring ways to enter China’s lucrative market and maximize their investment in the country. With limited resources, how can smaller companies operate efficiently and give Chinese patients access to their innovative products? A panel of experts explored these questions at the 2013 BIO CEO & Investor Conference. Jimmy Zhang from Merck moderated a panel including: Friedhelm Blobel, PhD, President, CEO, Read More >
BIO Travels to Brazil to Support the Ecosystem of Innovation
Government policies that support innovation are critical as the biotechnology industry seeks to develop innovative healthcare, agricultural, industrial and environmental biotechnology products and provide them to people all around the world. Innovation requires not only scientific research and commercial expertise, but also supportive and dynamic governments that help facilitate long-term growth of the industry. Brazil has recognized the value of innovation in maintaining a robust, diversified economy that can compete in the 21st century, and declared Read More >
BIO India Hosts Biopharmaceutical Regulatory and Policy Roundtable
During last week’s BIO India International Conference, BIO, in partnership with the Association of Biotech-Led Enterprises (ABLE) and the Confederation of Indian Industries (CII) held a roundtable to discuss ways that U.S. and Indian industry can work together to facilitate the development of new biotechnology products and commercialization. Participants in the roundtable represented U.S. and Indian industry, academia, and government and shared their views on critical issues important to the development of the Indian biotechnology Read More >
2012 BIO India International Conference: Top Five Reasons to Attend
The third annual BIO India International Conference will be held September 12-13 at the Grand Hyatt in Mumbai, India. BIO India will feature high-level keynote speakers, education panels on the latest trends, networking opportunities, company presentations and partnering meeting opportunities through the BIO One-on-One Partnering™ system. The event is particularly relevant and timely for those looking to learn more about India’s rapidly growing global presence in the life sciences. Read more to learn the top Read More >
BioWorld previews BIO India: India Emerges as Global Player via Multinational Partnering
BioWorld’s Tom Wall interviewed BIO’s Alan Eisenberg (subscription required) on what attendees can expect at this week’s BIO India International Partnering Conference. Interest in India has been strong and attendance at the conference is expected to surpass last year’s event. The population forecasted to grow in the coming years, combined with significant disease burden is a draw for many companies seeking business development and partnering opportunities. BIO India will feature keynote speakers Glenn Saldanha, Chairman Read More >
